Microbiologics – Page 2 – Medical Alley Association
Microbiologics, Inc.

Microbiologics Introduces the First SARS-CoV-2 RNA IVD CE Marked Control

Via Microbiologics St Cloud, MN – To help accelerate COVID-19 assay development and increase access to testing, Microbiologics is launching a SARS-CoV-2 IVD control within its popular Helix EliteTM line of molecular controls. This new IVD product provides quality control measures for the development, verification, and validation of diagnostic tests, with the unmatched precision and convenience of the Helix EliteTM line.  Featuring a large RNA molecule that matches the sequence of the virus N gene (which codes for the nucleocapsid phosphoprotein found […]

ST. CLOUD-BASED MICROBIOLOGICS FIGHTING COVID-19

Via WJON Radio In recent weeks, Microbiologics has been developing controls for much-needed testing kits, crucial in establishing an official diagnosis. The controls – pieces of the COVID-19’s genetic material – are not alive. They cannot grow or cause infection. But they are critical components of the kits Read More: St. Cloud-Based Microbiologics Fighting COVID-19  MAA […]

Medical Alley Association Advocacy Newsletter

Medical Alley is the global epicenter of health innovation and care, where healthcare leaders call home. In Medical Alley, you will find the world’s leading health technology innovation cluster, the highest ranked hospital, and the globally recognized Destination Medical Center. Medical Alley is also home to more than 1,000 healthcare companies, employing more than 500,000 […]

Microbiologics Appoints Raffaella Giardino as Vice President of Sales and Marketing

Giardino brings a history of strong leadership and over 20 years of experience in the life sciences industry Saint Cloud, Minn. –  Microbiologics, Inc. is pleased to announce that Raffaella Giardino, Ph.D., has been appointed as the company’s Vice President of Sales and Marketing. Dr. Giardino will lead strategy development and oversee execution for Microbiologics’ […]

In the Know: Healthcare News for November 11, 2019

Stryker announces definitive agreement to acquire Wright Medical for $5.4 Billion Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer Maple Grove-based Pursuit Vascular sold for $75 million to California firm Digi International spends $140 million to buy New Jersey IT company In $660 Million Deal, Takeda […]

Microbiologics Announces Acquisition of Michigan-Based Microbiology Laboratory Micromyx

St. Cloud, Minnesota – Microbiologics, Inc., the leading global provider of biomaterial controls, announced today that it has acquired Micromyx, a Michigan-based commercial microbiology laboratory. Micromyx is a recognized leader in the research, development, and registration of new antimicrobial agents for clients in the pharmaceutical, biotechnology and animal health industries. The company was founded in 2004 by […]

In the Know: Healthcare News for October 7, 2019

New M Health Fairview Brand Launches Cantel Medical closes Hu-Friedy buy University of Minnesota to test cancer-fighting ‘natural killer’ cells The Many Faces of Value-Based Healthcare Ecolab buys Australia’s Gallay Medical & Scientific U.S. Department of Defense Awards $6 Million to Humanetics Corporation for Advanced Development of Radioprotectant Late-Breaking Data Shows Abbott’s MitraClip is Cost […]

Microbiologics Adds Rifampicin-Resistant Mycobacterium tuberculosis To Its Molecular QC Offering

Positive and negative controls designed to help laboratories deliver reliable MTB-RIF testing results Saint Cloud, Minn. –  Microbiologics, Inc. has launched positive and negative controls for quality control of Rifampicin-Resistant Mycobacterium tuberculosis (MTB-RIF) molecular assays and test methods to help clinical laboratories deliver fast and accurate results. One fourth of the world’s population is infected […]

In the Know: Healthcare News for September 16, 2019

Google Works With Mayo Clinic to Share Health Knowledge Healthy.io Raises $60 Million in Series C Funding and Receives FDA Clearance for Smartphone-Based Test to Diagnose Chronic Kidney Disease Baxter puts up $230m for Cheetah Medical St. Thomas Announces Founding Dean for College of Health Heraeus to acquire Via Biomedical Imricor becomes second Minnesota IPO […]

In the Know: Healthcare News from Medical Alley, March 1, 2019

Tiny medical device designed in Minnesota repairs the tiniest hearts StemoniX lands $14.4M to develop ‘micro-organs’ – Minneapolis / St. Paul Business Journal Medtronic’s RF Ablation Platform FDA Cleared to Control Pain Mayo Clinic researchers identify gene that may predict pancreatic cancer in people with Type 2 diabetes Microbiologics rapidly evolving in the virology industry […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER